SAMIDINE

This brand name is authorized in Nigeria.

Active ingredients

The drug SAMIDINE contains one active pharmaceutical ingredient (API):

1
UNII 0N7609K889 - SULFADIAZINE
 

Sulfadiazine is an antibiotic that belongs to the class of drugs known as sulphonamides. Sulfadiazine is a structural analogue and competitive antagonist of p-aminobenzoic acid preventing bacterial utilisation of PABA in the synthesis of folic acid.

 
Read more about Sulfadiazine

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
04-0272 Tablet Samidine Tablet TAB 500 mg 762 Sulphadimidine 04-0272 Samidine Tablet Sulphadimidine, Maize Starch, Purified Talc, Magnesium Stearate, Gelatine, Methyl Paraben, Propyl Paraben, Starch For Paste Antibiotic Oral 500 mg,3.33 mg 10 mg, 8 mg, 2.67 mg, 1.2 mg, 0.2 mg,20 mg Tablet Prescription Only Medicine (Pom) Sam Pharmaceutical Limited Sam Pharmaceutical Ltd. Nigeria 2021-08-27 2026-08-26 27/08/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J01EC02 Sulfadiazine J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01E Sulfonamides and trimethoprim → J01EC Intermediate-acting sulfonamides
Discover more medicines within J01EC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database 04-0272

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.